Craig Mull is the Chairman and Interim Chief Executive Officer of Cipher Pharmaceuticals, a publicly traded company.
Craig Mull is the Chairman and Interim Chief Executive Officer of Cipher Pharmaceuticals, a publicly traded company. He holds 10.29 million shares, representing a ten percent ownership in the company. He has discussed the company's strategy to acquire and commercialize prescription medicines.
Full founder directory · Investor directory · Company funding database · Fundraising library